HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

CL 387785

structure in first source
Also Known As:
CL-387,785; CL-387785; EKI 785; EKI-785; N-(4-((3-bromophenyl)amino)-6-quinazolinyl)-2-butynamide; 2-Butynamide, N-(4-((3-bromophenyl)amino)-6-quinazolinyl)-
Networked: 12 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Avner, Ellis D: 2 articles (11/2004 - 11/2003)
2. Frost, Philip: 2 articles (11/2004 - 11/2003)
3. Harris, Peter C: 2 articles (11/2004 - 11/2003)
4. Qian, Qi: 2 articles (11/2004 - 11/2003)
5. Sweeney, William E: 2 articles (11/2004 - 11/2003)
6. Torres, Vicente E: 2 articles (11/2004 - 11/2003)
7. Wang, Xiaofang: 2 articles (11/2004 - 11/2003)
8. Cai, Yong: 1 article (03/2022)
9. Dong, Zhiyi: 1 article (03/2022)
10. Sheng, Zhaoying: 1 article (03/2022)

Related Diseases

1. Autosomal Recessive Polycystic Kidney (Polycystic Kidney Disease, Infantile, Type I)
2. Neoplasm Metastasis (Metastasis)
3. Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
4. Neoplasms (Cancer)
5. Adenocarcinoma of Lung

Related Drugs and Biologics

1. Erlotinib Hydrochloride (CP 358,774)
2. EKB 569
3. ErbB Receptors (EGF Receptor)
4. Urea (Carbamide)
5. Protein-Tyrosine Kinases (Tyrosine Kinase)
6. Nitrogen
7. Gefitinib (Iressa)
8. WZ4002
9. navitoclax
10. vandetanib (ZD6474)